Head-to-Head

Abbott Laboratories vs. Immunic, Inc. Common Stock

ABT

Abbott Laboratories

$103.54 +0.88%

VS IMUX

Immunic, Inc. Common Stock

$8.08 +1.25%

Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

ABTIMUX
Market Cap $177.61 billion $108.88 million

ABT leads on 1 of 1 size & scale factors.

Dividend

ABTIMUX
Dividend Yield 2.43% —

ABT and IMUX split the dividend factors evenly.

Risk & Sentiment

ABTIMUX
Short Interest 0.57% 2.84%

ABT leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABT overview, ABT financials, IMUX overview, IMUX financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.